1-3 of 3
Jason E. Farrar
Close
Sort by
Journal Articles

Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia

Oussama Abla, Rhonda E. Ries, Tim Triche, Jr, Robert B. Gerbing, Betsy Hirsch, Susana Raimondi, Todd Cooper, Jason E. Farrar, Nathaniel Buteyn, Lauren M. Harmon, Hong Wen, Aniruddha J. Deshpande, E. Anders Kolb, Alan S. Gamis, Richard Aplenc, Todd Alonzo, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2024) 8 (8): 2005–2017.
https://doi.org/10.1182/bloodadvances.2023010805
Published: 2024
Includes: Supplemental data
Journal Articles

CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies

Clinical Trials & Observations
Yixin Hu, Kenneth J. Caldwell, Mihaela Onciu, Sara M. Federico, Marta Salek, Sara Lewis, Shaohua Lei, Jinghui Zhang, Kim E. Nichols, Clifford M. Takemoto, Brandon M. Triplett, Jason E. Farrar, Jeffrey E. Rubnitz, Raul C. Ribeiro, Marcin W. Wlodarski
Journal: Blood Advances
Blood Adv (2022) 6 (2): 521–527.
https://doi.org/10.1182/bloodadvances.2021006139
Published: 2022
Includes: Supplemental data
Journal Articles

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes

Clinical Trials & Observations
Benjamin J. Huang, Jenny L. Smith, Yi-Cheng Wang, Kassra Taghizadeh, Amanda R. Leonti, Rhonda E. Ries, Yanling Liu, Pandurang Kolekar, Katherine Tarlock, Robert Gerbing, Erin Crowgey, Scott N. Furlan, Timothy I. Shaw, Kohei Hagiwara, Lisa Wei, Todd M. Cooper, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Jason E. Farrar, Timothy Triche, Jr, Todd A. Alonzo, Xiaotu Ma, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4963–4968.
https://doi.org/10.1182/bloodadvances.2021004965
Published: 2021
Includes: Supplemental data